ReachMD
ReachMD CME
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.
Bezoek zeker de website van de podcast en steun de maker: reachmd.com
Auteur
ReachMD
Categorie
Website van de podcast
Nieuwste aflevering
20 okt. 2026
Waar luisteren?
Podcasts in de app Replaio Radio Binnenkort beschikbaarPodcasts komen binnenkort naar de app. Installeer nu en zie als eerste een compleet nieuwe kijk op podcasts
Afleveringen
When Itching Hurts: Quality of Life Disruption in CKD-aP 17.08.2026 5:30
CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/when-itching-hurts-quality-of-life-disruption-in-ckd-ap/60994/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures,...
CKD-aP Uncovered Prevalence & Pathophysiology 17.08.2026 5:15
CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/ckd-ap-uncovered-prevalence-pathophysiology/60993/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brief lectures, the series...
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care 17.08.2026 7:30
CME credits: 1.00 Valid until: 17-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/frontline-champions-nurses-as-drivers-of-symptom-based-ckd-ap-care/54094/ Join faculty experts in reviewing best practices for chronic kidney disease–associated pruritus (CKD-aP), a common but under-recognized symptom affecting patients with CKD. Through expert interviews, case discussions, and brie...
Conference Coverage at ICCBH 2026: From Achondroplasia Presentation to Practice 14.08.2026 16:30
CME credits: 0.25 Valid until: 14-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/conference-coverage-at-iccbh-2026-from-achondroplasia-presentation-to-practice/57925/ In this expert discussion, Drs. Ravi Savarirayan and Julie Hoover-Fong examine how findings from the PROPEL 3 trial of oral infigratinib fit within the evolving treatment landscape for achondroplasia in children. T...
Menin Inhibitors in AML: Six Clinical Showdowns That Shape Real-World Practice 10.08.2026 32:30
CME credits: 0.50 Valid until: 10-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/menin-inhibitors-in-aml-six-clinical-showdowns-that-shape-real-world-practice/57259/ This chapterized expert interview examines six common clinical decision points encountered when incorporating menin inhibitors into the management of relapsed/refractory NPM1-mutated acute myeloid leukemia (AML). Fa...
Case Consult: Targeting CDH6 in Platinum-Resistant Ovarian Cancer 07.08.2026 10:00
CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-targeting-cdh6-in-platinum-resistant-ovarian-cancer/60967/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence supporting PARP inhibi...
Case Consult: Treatment Strategies for HER2-Positive Platinum-Resistant Ovarian Cancer 07.08.2026 10:30
CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-treatment-strategies-for-her2-positive-platinum-resistant-ovarian-cancer/60966/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence s...
Case Consult: Treatment Strategies for FRα-Positive Platinum-Resistant Ovarian Cancer 07.08.2026 9:30
CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-treatment-strategies-for-fr-positive-platinum-resistant-ovarian-cancer/60965/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence sup...
Case Consult: PD-L1–Guided Treatment Decisions in Platinum-Resistant Ovarian Cancer 07.08.2026 9:30
CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/case-consult-pd-l1guided-treatment-decisions-in-platinum-resistant-ovarian-cancer/60964/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence suppo...
Case Consult: Personalizing First-Line Maintenance Therapy in Advanced Ovarian Cancer 07.08.2026 11:30
CME credits: 1.00 Valid until: 07-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/Case-Consult-Personalizing-First-Line-Maintenance-Therapy-in-Advanced-Ovarian-Cancer/60963/ This online educational activity uses real-world patient cases to explore biomarker-driven treatment strategies across the advanced ovarian cancer continuum. Expert faculty review pivotal clinical evidence su...
Raising the Bar for Hodgkin Lymphoma: Optimizing Immunotherapy in Community Practice 05.08.2026 35:00
CME credits: 1.00 Valid until: 05-08-2027 Claim your CME credit at https://reachmd.com/programs/cme/raising-the-bar-for-hodgkin-lymphoma-optimizing-immunotherapy-in-community-practice/56816/ This online activity is designed to provide the healthcare team with the latest developments and critical insights into Hodgkin lymphoma treatment. This education will support the healthcare professional in hi...
Rewriting the Calcium Code in ADH1 31.07.2026 17:31
CME credits: 0.25 Valid until: 31-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/rewriting-the-calcium-code-in-adh1/54833/ In this expert discussion, Drs. Michael Levine and Aliya Khan review emerging evidence in autosomal dominant hypocalcemia type 1 (ADH1), including findings from the CALIBRATE trial presented at ENDO 2026. They discuss how CaSR-targeted therapy with encaleret...
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs 29.07.2026 27:16
CME credits: 0.50 Valid until: 29-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/Redefining-Durability-in-nAMD-The-Science-and-Strategy-of-Sustained-Delivery-TKIs/59172/ While anti-VEGF biologics have transformed outcomes in neovascular age-related macular degeneration (nAMD), real-world data continue to show that visual gains achieved in clinical trials are not consistently rep...
On the Horizon: Emerging Antigen-Directed Strategies Across Disease Stage 27.07.2026 5:45
CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/on-the-horizon-emerging-antigen-directed-strategies-across-disease-stage/60951/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antige...
Clinical Evidence on Emerging Antigen-Directed Strategies in ES-SCLC 27.07.2026 5:30
CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/clinical-evidence-on-emerging-antigen-directed-strategies-in-es-sclc/60950/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens s...
Rationale of Emerging Antigen-Directed Strategies in Frontline ES-SCLC 27.07.2026 4:30
CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/rationale-of-emerging-antigen-directed-strategies-in-frontline-es-sclc/60949/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting antigens...
The Survival Ceiling in ES-SCLC: Why Checkpoint Blockade Alone Is Not Enough 27.07.2026 5:00
CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/the-survival-ceiling-in-es-sclc-why-checkpoint-blockade-alone-is-not-enough/60948/ This online educational activity examines next-generation therapeutic approaches for small cell lung cancer (SCLC) beyond traditional checkpoint inhibition. The program reviews the biologic rationale for targeting ant...
Translating Research Into Practice in Breast Cancer: Emerging Data and the Expanding Role of ADCs 27.07.2026 31:00
CME credits: 0.50 Valid until: 27-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/translating-research-into-practice-in-breast-cancer-emerging-data-and-the-expanding-role-of-adcs/57226/ The role of antibody-drug conjugate (ADC) therapy has been well established in metastatic breast cancer. Recent phase 3 data have provided evidence for expanded indications for early breast cancer...
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives 24.07.2026 1:05:30
CME credits: 1.50 Valid until: 24-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/advancing-acromegaly-care-diving-deeper-into-diagnosis-guideline-application-and-emerging-therapiesa-fireside-chat-with-expert-perspectives/56307/ This program is a replay of the live symposium held at ENDO 2026. This program reviews challenges in diagnosis and management of acromegaly, with an emph...
From Data to Decision: Patient Selection and Real-World Application 23.07.2026 5:15
CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/from-data-to-decision-patient-selection-and-real-world-application/60855/ This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for...
Building the Team: Integrating Immunotherapy Into Multidisciplinary Care 23.07.2026 7:30
CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/building-the-team-integrating-immunotherapy-into-multidisciplinary-care/60854/ This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale...
The Evidence Base: Key Trials and Emerging Data 23.07.2026 5:00
CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/the-evidence-base-key-trials-and-emerging-data/60853/ This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale for integrating immune c...
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC 23.07.2026 4:15
CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/the-case-for-change-why-perioperative-immunotherapy-matters-in-la-hnscc/60852/ This educational series examines the evolving role of perioperative immunotherapy in resectable, locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Drs. Le Tourneu and Oliva review the scientific rationale...
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies 22.07.2026 16:30
CME credits: 0.50 Valid until: 23-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/from-abstract-to-action-in-breast-cancer-interpreting-recent-data-on-oral-serds-and-endocrine-targeting-strategies/57230/ Oral selective estrogen receptor degraders (SERDs) are rapidly reshaping the treatment landscape in breast cancer, offering targeted treatment approaches that have demonstrated i...
Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations 20.07.2026 43:15
CME credits: 1.00 Valid until: 20-07-2027 Claim your CME credit at https://reachmd.com/programs/cme/clear-skin-clear-path-transforming-psoriasis-care-with-durable-biologic-and-oral-il-23-innovations/49227/ Psoriasis management often begins with topical therapies, phototherapy, or established biologics before escalation. This Broadcast Replay examines earlier biologic use and the role of oral IL-23...
Vergelijkbare podcasts
Replaio is geen uitgever van podcasts; namen van shows, covers en audio zijn eigendom van hun makers en worden verspreid via openbare RSS-feeds